SCHEMBL23905623

SCHEMBL23905623

O=C(NCC(c1cc2c(c(-c3ccc(F)cc3)n1)OCC2(CF)CF)C1CC1)c1cc(OC2CC2)c2ncc(F)cc2c1

nearest known ligand 0.32

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.32
AR P10275 1/20 0.31
BCL9 O00512 2/20 0.30
CTNNB1 P35222 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905973 0.95 IRAK4 (0.32) IRAK4AR
SCHEMBL23904705 0.91
SCHEMBL23904706 0.83
SCHEMBL23905281 0.81
SCHEMBL23196168 0.81 AR (0.34) AR
SCHEMBL23905301 0.79 IP6K1 (0.31) IRAK4AR
SCHEMBL23905266 0.78 GABRA5 (0.31)
SCHEMBL23905641 0.78 LMNA (0.33)
SCHEMBL23717442 0.77 SLC5A7 (0.33) BCL9CTNNB1
SCHEMBL23905613 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed